PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7912015-6	1994	Consequently, 2-CdA is expected soon to displace both interferon alpha and deoxycoformycin as first line therapy in hairy cell leukemia.	Pentostatin	75-90	cytidine deaminase	Homo sapiens	16-19	
9178835-2	1997	Recently, the high activity of nucleoside analogs as fludarabine (FAMP), 2-chlorodeoxyadenosine (2-CDA) and 2-deoxycoformycin (DCF) in low-grade NHLs has caused a new reawakening interest in CLL concerning new treatment strategies, the biology and prognostic factors of this disease.	Pentostatin	127-130	cytidine deaminase	Homo sapiens	99-102	
21463108-8	2011	These additional modes of action produce further DNA breaks in CdA-treated cells and explain the more potent activity of CdA compared to dCF and the greater myelosuppression with this agent.	Pentostatin	137-140	cytidine deaminase	Homo sapiens	63-66	
7685243-6	1993	Recently, the nucleosides pentostatin (2"-deoxycoformycin) (DCF) and 2"-chlorodeoxyadenosine (2-CdA) have been shown to produce greater numbers of durable complete remissions with curative potential in patients with HCL.	Pentostatin	60-63	cytidine deaminase	Homo sapiens	96-99	
1279327-2	1992	Splenectomy as first line therapy has few indications; recombinant alfa interferon (IFN) leads to a high overall response rate but there are few bone marrow remissions; deoxycoformycin (dCF) or pentostatin leads to a higher complete bone marrow response rate than with IFN but follow-up biopsies show persistence of hairy cells; 2-chlorodeoxyadenosine (2-CdA) is a purine analog that after a single seven day intravenous infusion leads to a complete response rate.	Pentostatin	169-184	cytidine deaminase	Homo sapiens	355-358